dc.creator | González-Reyes R.E. | |
dc.creator | Aliev G. | |
dc.creator | Ávila-Rodrigues M. | |
dc.creator | Barreto G.E. | |
dc.date.accessioned | 2020-09-02T22:19:24Z | |
dc.date.accessioned | 2022-11-08T20:26:21Z | |
dc.date.available | 2020-09-02T22:19:24Z | |
dc.date.available | 2022-11-08T20:26:21Z | |
dc.date.created | 2020-09-02T22:19:24Z | |
dc.date.issued | 2016 | |
dc.identifier | 22, 7, 812-818 | |
dc.identifier | 13816128 | |
dc.identifier | https://hdl.handle.net/20.500.12728/4730 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5146024 | |
dc.language | en | |
dc.publisher | Bentham Science Publishers | |
dc.subject | Alzheimer disease | |
dc.subject | Antidiabetic drugs | |
dc.subject | Dementia | |
dc.subject | Diabetes | |
dc.subject | Insulin resistance | |
dc.subject | amyloid beta protein | |
dc.subject | amyloid precursor protein | |
dc.subject | antidiabetic agent | |
dc.subject | free radical | |
dc.subject | glucagon like peptide 1 | |
dc.subject | glucose transporter 1 | |
dc.subject | intranasal insulin | |
dc.subject | lactic acid | |
dc.subject | tau protein | |
dc.subject | unclassified drug | |
dc.subject | antidiabetic agent | |
dc.subject | glucose | |
dc.subject | insulin | |
dc.subject | Alzheimer disease | |
dc.subject | apoptosis | |
dc.subject | Article | |
dc.subject | astrocyte | |
dc.subject | brain function | |
dc.subject | brain metabolism | |
dc.subject | carbohydrate metabolism | |
dc.subject | cell activation | |
dc.subject | cell metabolism | |
dc.subject | cognition | |
dc.subject | dementia | |
dc.subject | dendrite | |
dc.subject | diabetes mellitus | |
dc.subject | disease association | |
dc.subject | gene expression | |
dc.subject | glucose blood level | |
dc.subject | glucose brain level | |
dc.subject | glucose metabolism | |
dc.subject | human | |
dc.subject | hyperglycemia | |
dc.subject | hypoglycemia | |
dc.subject | insulin dependent diabetes mellitus | |
dc.subject | insulin resistance | |
dc.subject | memory | |
dc.subject | nervous system inflammation | |
dc.subject | non insulin dependent diabetes mellitus | |
dc.subject | osmotic pressure | |
dc.subject | oxidative stress | |
dc.subject | priority journal | |
dc.subject | protein phosphorylation | |
dc.subject | synapse | |
dc.subject | Alzheimer disease | |
dc.subject | animal | |
dc.subject | complication | |
dc.subject | dementia | |
dc.subject | Diabetes Mellitus, Type 1 | |
dc.subject | Diabetes Mellitus, Type 2 | |
dc.subject | metabolism | |
dc.subject | pathophysiology | |
dc.subject | risk factor | |
dc.subject | Alzheimer Disease | |
dc.subject | Animals | |
dc.subject | Dementia | |
dc.subject | Diabetes Mellitus, Type 1 | |
dc.subject | Diabetes Mellitus, Type 2 | |
dc.subject | Glucose | |
dc.subject | Humans | |
dc.subject | Hypoglycemic Agents | |
dc.subject | Insulin | |
dc.subject | Risk Factors | |
dc.title | Alterations in glucose metabolism on cognition: A possible link between diabetes and dementia | |
dc.type | Article | |